Follow
Inflammatory Tumor Microenvironment
The Tumor Microenvironment encompasses the healthy cells, molecules, and blood vessels that surround cancer, providing nutrients and blood to support tumor growth. A tumor can alter its microenvironment in order to promote growth and progression. An Inflammatory Tumor Microenvironment contains molecules, including inflammatory cytokines (like interferons, and IL-6) and inflammatory immune cells (like myeloid-derived suppressor cells and tumor associated macrophages).
-
APR 25, 2023 | 8:00 AM
Date: April 25, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Several promising immunotherapies have emerged in recent decades due to advances in cancer immunology. The paradigm o...NOV 03, 2022 | 6:00 AM
Date: October 13, 2022 Time: 10:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Most known immune checkpoints exert their effects upon protein-protein interactions, such as the PD1 checkpoint on CD...JUL 12, 2022 | 8:00 AM
Date: July 12, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) Dendritic cells (DCs) are a heterogeneous population of myeloid immune cells that act as peripheral sentinels specializin...NOV 09, 2021 | 8:00 AM
Date: November 09, 2021 Time: 8:00am (PDT), 11:00am (EDT) Myeloid cells comprise many subsets with diverse functions. They play an important role in health and diseases such as infections, c...JUN 02, 2021 | 12:00 AM
Despite the promising results with current approved immunotherapies, all patients do not have the same level of response, and recent efforts have focused on understanding and avoiding immuno...OCT 20, 2020 | 9:00 AM
DATE: October 20th, 2020 TIME: 08:00am PT, 11:00am ET Tumor-associated macrophages (TAMs) are key cells in the tumor microenvironment (TME) with diverse immune functions that have a major in...OCT 07, 2020 | 10:30 AM
Tumor phenotypes are dictated not only by the neoplastic cell component, but also by the tumor microenvironment (TME), which is inherently immuno-suppressive, is equipped to hamper effector...Speaker: Dr. Sergio RutellaPresented at: Cancer Research & Oncology Week Virtual Event Series 2020
Sponsored By: NanoString TechnologiesSEP 23, 2020 | 10:30 AM
Speaker TBD 10:30–10:50 am PDT Exploring the immune tumor microenvironment of hepatocellular carcinoma with Imaging Mass Cytometry™ 10:50 am–11:10 am PDT Presented By: Won...Speaker: Won Jin Ho, MD , Melissa B. Davis, PhDPresented at: 9th Annual Fluidigm Mass Cytometry Virtual Summit
SEP 23, 2020 | 6:30 AM
Single-cell mass cytometry identifies mechanisms of resistance to immunotherapy in AML 6:30–7:00 am PDT Presented By: Shelley Herbrich, PhD Understanding CD19 negative relapse followin...Speaker: Shelley Herbrich, PhD , Kara L. Davis, DO , Bernd Bodenmiller, PhDPresented at: 9th Annual Fluidigm Mass Cytometry Virtual Summit
SEP 01, 2020 | 8:00 AM
DATE: September 1, 2020 TIME: 8:00am PT, 11:00am ET Nearly half of all cancer patients are eligible to receive treatment with immune checkpoint inhibitors (ICI). Thus, preventing, identifyin...JUN 03, 2020 | 12:00 AM
Learning Objectives: 1. Define applications of approved and experimental (multiplexing IF) biomarker assessment in Immuno-Oncology 2. Define bottlenecks and areas of improvement to current t...MAY 20, 2020 | 11:45 AM
Tumor phenotypes are dictated not only by the neoplastic cell component, but also by the tumor microenvironment (TME), which is inherently immuno-suppressive, is equipped to hamper effector...Speaker: Sergio Rutella, MD, PhD, FRCPathPresented at: Advancing Science - A Virtual Oncology Conference
APR 14, 2020 | 9:00 AM
DATE: April 14, 2020 TIME: 9:00am PDT, 12:00pm EDT Besides being Gibco Cell Culture Heroes, what do Vivek, Sandra, Daisy, Ameet and Kristine all have in common? They are all stuck at home fo...Speaker: Kristine Wadosky, PhD , Ameet Chimote, PhD , Elizabeth Delery, PhD , Daisy Shu, B.Optom, PhD , Vivek Kamat, PhD , Sandra Hammer, PhDSponsored By: Thermo Fisher Scientific/GibcoNOV 07, 2019 | 10:00 AM
DATE: November 7, 2019TIME: 10:00am PST, 1:00pm EST Studying the pathogenesis of diabetes requires detailed analysis of the pancreatic islet microenvironment and its numerous c...SEP 27, 2019 | 9:00 AM
DATE: September 27, 2019TIME: 9:00am PT, 12:00pm ET Thienopyrazole derivatives have recently emerged as effective antitumoral agents with kinase inhibitory activity. In this s...AUG 15, 2019 | 9:00 AM
DATE: August 15, 2019TIME: 9:00am PDT, 12:00pm EDT Radiation therapy is a critical tool for the treatment of brain tumors, however, exposure to high doses of ionizing radiation...JUL 31, 2019 | 9:00 AM
DATE: July 31, 2019TIME: 9:00am PT, 12:00pm ET The choroid plexus, which makes up the blood-cerebrospinal fluid barrier in the central nervous system (CNS), lines the ventricle...NOV 14, 2017 | 10:00 AM
DATE: November 14, 2017TIME: 10:00am PST, 1:00pm ESTSuccessful tumor outgrowth requires the coordination of a variety of cell intrinsic and cell extrinsic signaling events. These events...Speaker: Jeffrey Rodvold, PhDSponsored By: Thermo Fisher Scientific/Gibco, Thermo Fisher Scientific/Gibco
APR 25, 2023 | 8:00 AM
Date: April 25, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Several promising immunotherapies have emerged in recent decades due to advances in cancer immunology. The paradigm o...
NOV 03, 2022 | 6:00 AM
Date: October 13, 2022 Time: 10:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Most known immune checkpoints exert their effects upon protein-protein interactions, such as the PD1 checkpoint on CD...
JUL 12, 2022 | 8:00 AM
Date: July 12, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) Dendritic cells (DCs) are a heterogeneous population of myeloid immune cells that act as peripheral sentinels specializin...
NOV 09, 2021 | 8:00 AM
Date: November 09, 2021 Time: 8:00am (PDT), 11:00am (EDT) Myeloid cells comprise many subsets with diverse functions. They play an important role in health and diseases such as infections, c...
JUN 02, 2021 | 12:00 AM
Despite the promising results with current approved immunotherapies, all patients do not have the same level of response, and recent efforts have focused on understanding and avoiding immuno...
OCT 20, 2020 | 9:00 AM
DATE: October 20th, 2020 TIME: 08:00am PT, 11:00am ET Tumor-associated macrophages (TAMs) are key cells in the tumor microenvironment (TME) with diverse immune functions that have a major in...
OCT 07, 2020 | 10:30 AM
Tumor phenotypes are dictated not only by the neoplastic cell component, but also by the tumor microenvironment (TME), which is inherently immuno-suppressive, is equipped to hamper effector...
Speaker:
Dr. Sergio Rutella
Presented at: Cancer Research & Oncology Week Virtual Event Series 2020
Sponsored By: NanoString Technologies
Sponsored By: NanoString Technologies
SEP 23, 2020 | 10:30 AM
Speaker TBD 10:30–10:50 am PDT Exploring the immune tumor microenvironment of hepatocellular carcinoma with Imaging Mass Cytometry™ 10:50 am–11:10 am PDT Presented By: Won...
Speaker:
Won Jin Ho, MD
, Melissa B. Davis, PhD
Presented at: 9th Annual Fluidigm Mass Cytometry Virtual Summit
SEP 23, 2020 | 6:30 AM
Single-cell mass cytometry identifies mechanisms of resistance to immunotherapy in AML 6:30–7:00 am PDT Presented By: Shelley Herbrich, PhD Understanding CD19 negative relapse followin...
Speaker:
Shelley Herbrich, PhD
, Kara L. Davis, DO
, Bernd Bodenmiller, PhD
Presented at: 9th Annual Fluidigm Mass Cytometry Virtual Summit
SEP 01, 2020 | 8:00 AM
DATE: September 1, 2020 TIME: 8:00am PT, 11:00am ET Nearly half of all cancer patients are eligible to receive treatment with immune checkpoint inhibitors (ICI). Thus, preventing, identifyin...
JUN 03, 2020 | 12:00 AM
Learning Objectives: 1. Define applications of approved and experimental (multiplexing IF) biomarker assessment in Immuno-Oncology 2. Define bottlenecks and areas of improvement to current t...
MAY 20, 2020 | 11:45 AM
Tumor phenotypes are dictated not only by the neoplastic cell component, but also by the tumor microenvironment (TME), which is inherently immuno-suppressive, is equipped to hamper effector...
Speaker:
Sergio Rutella, MD, PhD, FRCPath
Presented at: Advancing Science - A Virtual Oncology Conference
APR 14, 2020 | 9:00 AM
DATE: April 14, 2020 TIME: 9:00am PDT, 12:00pm EDT Besides being Gibco Cell Culture Heroes, what do Vivek, Sandra, Daisy, Ameet and Kristine all have in common? They are all stuck at home fo...
Speaker:
Kristine Wadosky, PhD
, Ameet Chimote, PhD
, Elizabeth Delery, PhD
, Daisy Shu, B.Optom, PhD
, Vivek Kamat, PhD
, Sandra Hammer, PhD
Sponsored By: Thermo Fisher Scientific/Gibco
NOV 07, 2019 | 10:00 AM
DATE: November 7, 2019TIME: 10:00am PST, 1:00pm EST Studying the pathogenesis of diabetes requires detailed analysis of the pancreatic islet microenvironment and its numerous c...
SEP 27, 2019 | 9:00 AM
DATE: September 27, 2019TIME: 9:00am PT, 12:00pm ET Thienopyrazole derivatives have recently emerged as effective antitumoral agents with kinase inhibitory activity. In this s...
AUG 15, 2019 | 9:00 AM
DATE: August 15, 2019TIME: 9:00am PDT, 12:00pm EDT Radiation therapy is a critical tool for the treatment of brain tumors, however, exposure to high doses of ionizing radiation...
JUL 31, 2019 | 9:00 AM
DATE: July 31, 2019TIME: 9:00am PT, 12:00pm ET The choroid plexus, which makes up the blood-cerebrospinal fluid barrier in the central nervous system (CNS), lines the ventricle...
NOV 14, 2017 | 10:00 AM
DATE: November 14, 2017TIME: 10:00am PST, 1:00pm ESTSuccessful tumor outgrowth requires the coordination of a variety of cell intrinsic and cell extrinsic signaling events. These events...
Speaker:
Jeffrey Rodvold, PhD
Sponsored By: Thermo Fisher Scientific/Gibco,
Thermo Fisher Scientific/Gibco